“Where Do Things Stand?” and Other Common Pleas from Clinical Trial Sponsors”
Ellie Brightman May 1, 2026
Sponsors often describe their challenges in clinical trials using familiar terms: oversight, timelines, compliance, and coordination. Beneath all these concerns sits a quieter but more persistent issue: portfolio visibility. Most sponsor organizations do not struggle because they lack data. They struggle because the same information exists in multiple places, in slightly different forms, at different points in time. When leadership
